Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-582-4 | CAS number: 1471315-26-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 5 Jan - 4 Feb 2010
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP-Guideline study, tested with the source substance aluminium hydroxide. According to the ECHA guidance document "Practical guide 6: How to prepare read-across and categories (March 2010)", the reliability was changed from RL1 to RL2 to reflect that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Harmonised Tripartite Guideline (European Agency for the Evaluation of Medicinal Products. (1995) ICH Topic S 2 A. “Genotoxicity: Guidance on Specific Aspects of Genotoxicity Tests for Pharmaceuticals”).
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Aluminium hydroxide
- EC Number:
- 244-492-7
- EC Name:
- Aluminium hydroxide
- Cas Number:
- 21645-51-2
- Molecular formula:
- AlH3O3
- IUPAC Name:
- aluminum trihydroxide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Al(OH)3 /SH-20 Muster
- Physical state: white powder
- Analytical purity: 99%
- Composition of test material, percentage of components: Al2O3, 65.1±0.3%, SiO2, 0.007%, Fe2O3, 0.006%, TiO2, 0.001%, CaO, 0.003%, Na2Oges, 0.18%, V2O5, <0.001%, P2O5, <0.001%, ZnO, <0.001%, Ga2O3, 0.005%
- Lot/batch No.: 40/2009
- Expiration date of the lot/batch: week 40, 2034
- Storage condition of test material: at 15-25 °C in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, UK
- Age at study initiation: range-finding study: 6-10 weeks; main experiment: 8 weeks
- Weight at study initiation: range-finding study: 181-190 g; main experiment: 217-260 g
- Assigned to test groups randomly: yes (main experiment)
- Housing: up to 6 animals per cage
- Diet: SQC Rat and Mouse Maintenance Diet No 1, Expanded (Special Diets Services Ltd. Witham), ad libitum
- Water: mains water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 40-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: carboxymethylcellulose in deionised water (1% CMC)
- Justification for choice of solvent/vehicle: CMC is a well-known vehicle, and it was tested previously in the test laboratory
-- Amount of vehicle: 10 mL/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The dosing solutions were freshly prepared by mixing with a Silverson homogenizer until visibly homogenous. Dose bottles were stirred continuously on a magnetic stirrer before and throughout dosing. The dosing solutions were used within 2 h. - Duration of treatment / exposure:
- 2 days
- Frequency of treatment:
- daily
- Post exposure period:
- 24 h after treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000 and 2000 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- range-finding study: 3 (males and females)
main experiment: 6 (male) - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): due to the known properties of inducing micronuclei formation, cyclophosphamid was selected as appropriate positive control.
- Route of administration: oral (24 h prior to necropsy)
- Doses / concentrations: 20 mg/kg bw
Examinations
- Tissues and cell types examined:
- Tissue: bone marrow
Cell type: bone marrow cells - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Range-finding study performed to find the maximum tolerated dose.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): One bone marrow sample was taken 24 h after the final treatment.
DETAILS OF SLIDE PREPARATION: Slides were stained with acridine orange and scored using fluorescence microscopy.
METHOD OF ANALYSIS: Slides from all groups were arranged by randomly allocated animal number and analyzed by an individual unaware of the animals’ dose group. Scoring was therefore blinded.
The relative proportion of polychromatic erythrocytes (%PCE) was determined by analyzing at least 1000 cells - polychromatic plus normochromatic erythrocytes (NCE).
Frequency of micronucleated PCE (% MN PCE) was determined by analysis for micronuclei (MN) of at least 2000 PCE per animal. - Evaluation criteria:
- For the test article to be considered positive (inducing clastogenic/aneugenic damage), all of the following 4 criteria are to be met:
1. A statistically significant increase in the frequency of MN PCE occurred at one or more dose levels
2. The incidence and distribution of MN PCE in individual animals at such a point exceeded the laboratory’s historical vehicle control data
3. The group mean MN PCE value at such a point exceeds the 95% calculated confidence interval for the mean historical vehicle control data
4. A dose-response trend in the proportion of MN PCE was observed (where more than two dose levels were analysed)
If none of the 4 criteria are met, the test article is to be considered negative in this assay.
Results only partially satisfying the above criteria are to be considered on a case-by-case basis. Biological relevance is to be taken into account (e.g. consistency of response within and between dose levels). - Statistics:
- Heterogeneity chi-square test was used for evaluation of inter-individual variation in the numbers of MN PCE for each group.
A 2x2 contingency table and chi-square test was used to compare the numbers of MN PCE in each treated group with the numbers in vehicle control groups
A test for linear trend was used to evaluate possible dose-response relationship.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2000 mg/kg bw
- Clinical signs of toxicity in test animals: No clinical signs of toxicity, nor effects on body weight or core temperature were observed in the range-finding study.
RESULTS OF DEFINITIVE STUDY
1. The frequency and distribution of MN PCE in the vehicle control group were similar to the historical vehicle control data.
2. There was a significant increase in the frequency of MN PCE (% MN PCE) in the positive control group
3. There was no evidence of test-substance-induced bone marrow toxicity, i.e. no decrease in the relative proportions of PCE (%PCE) compared to the vehicle control group and no dose-dependent decrease in %PCE; %PCE in the treated groups were even slightly higher than in the non-treated groups.
4. Group mean frequencies of MN PCE (% MN PCE) in all three dose groups were similar to and not significantly different from those in the vehicle control group.
5. Individual %MN PCE for all treated animals were within the range of historical vehicle control distribution data and similar to those observed in recent historical controls.
General toxicity:
No clinical signs of toxicity were observed in any animal in any group (vehicle control, positive control or any dose group)
Body weight:
No effect was observed on body weight.
Any other information on results incl. tables
Table 1: Results after exposure to aluminium hydroxide
Group %PCE MN PCE/2000 PCE %MN PCE
(dose) (SD)
-------------------------------------------------------------------------
0 49.35 2.67 0.13 (0.10)
500 58.55 2.33 0.12 (0.09)
1000 53.08 2.83 0.14 (0.09)
2000 54.82 2.50 0.13 (0.06)
PC* 46.13 55.50 2.78 (1.60)
-------------------------------------------------------------------------
*PC-positive controlApplicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
